Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy

Pathophysiology : the Official Journal of the International Society for Pathophysiology
Benedict S. Maniscalco, Karen A. Taylor

Abstract

Atherosclerosis is a complex process with multiple mechanisms and factors contributing to its initiation and progression. Detection and quantification of coronary artery calcium (CAC) scores with electron beam tomography has been shown to correlate with obstructive and nonobstructive coronary artery disease (CAD). Pathogen-triggered calcification could play a role in CAD. Recent reports suggest that infectious blood nanobacteria (NB) emerge to be such a trigger. So far, minimal or no reversal of atherosclerosis has been claimed by therapies with iv ethylenediaminetetraacetic acid disodium salt (EDTA), antibiotics, or other regimens, and therapies for atherosclerosis remain non-curative. We have now combined EDTA with antibiotic tetracycline (comET), an in vitro proven nanobacteriocidal treatment, and tested comET therapy in patients with documented CAD. Three hypotheses were probed: (1) Are NB present in patients with CAD?; (2) Does treatment with comET affect blood NB antigen and serology?; (3) Does a comET decrease CAC scores? One hundred patients with stable CAD and positive CAC scores were enrolled into a 4 month study of comET therapy. ComET therapy is composed of (1) Nutraceutical Powder (Vitamin C, Vitamin B6, Niacin, Fo...Continue Reading

References

Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·E O Kajander, N Ciftçioglu
Jun 9, 2000·Kidney International·J T HjelleF S Darras
Jun 27, 2000·The American Journal of Cardiology·M J BudoffB H Brundage
Mar 21, 2002·Diabetes, Obesity & Metabolism·D A EvansS Sobki
Jun 19, 2002·Trends in Cardiovascular Medicine·Burkhard LudewigHans Hengartner
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·N CíftçíogluE O Kajander
Apr 8, 2003·Current Pharmaceutical Design·M J SierevogelB H Strauss
Aug 27, 2003·Circulation·Neva CiftçioğluE Olavi Kajander
Feb 26, 2004·Southern Medical Journal·Tomislav M JelicHo-Huang Chang
May 15, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Virginia M MillerJohn C Lieske

❮ Previous
Next ❯

Citations

Dec 18, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Willi Jahnen-DechentMarc D McKee
Mar 5, 2013·Calcified Tissue International·Meiting WuCecilia M Giachelli
Jan 13, 2006·World Journal of Urology·Hadley M Wood, Daniel A Shoskes
Jun 28, 2005·Current Urology Reports·Daniel A Shoskes, Erin Katz
May 29, 2007·PLoS Pathogens·Pasquale Urbano, Francesco Urbano
Apr 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jan Martel, John Ding-E Young
Jul 4, 2012·Revista Española De Cardiología·Ignasi BarbaDavid Garcia-Dorado
Mar 9, 2010·European Journal of Radiology·Markus SchwaigerStephan G Nekolla
Feb 24, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Alicia BasEscolastico Aguilera-Tejero
May 19, 2006·Letters in Applied Microbiology·E O Kajander
Dec 16, 2006·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Neva CiftciogluE Olavi Kajander
Nov 24, 2004·International Journal of Antimicrobial Agents·Andrei P Sommer, N Chandra Wickramasinghe
Dec 5, 2006·Medical Hypotheses·Mesrur Selcuk Silay, Cengiz Miroglu
Jun 7, 2014·Frontiers in Microbiology·Anton G KutikhinAlexey S Golovkin
Jun 22, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ji-Hua WuXiao-Feng Guan
Feb 6, 2020·Tropical Animal Health and Production·Usama T MahmoudMohamed A Osman
May 1, 2021·Biomedicines·Prabhatchandra DubeDavid Kennedy
Apr 13, 2005·Journal of Proteome Research·Andrei P Sommer, Attila E Pavláth
Oct 4, 2021·Environmental Science and Pollution Research International·Parna DuttaSantanu Chakraborty

❮ Previous
Next ❯

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

American Journal of Physiology. Heart and Circulatory Physiology
Virginia M MillerJohn C Lieske
Proceedings of the National Academy of Sciences of the United States of America
J O CisarD J Kopecko
© 2021 Meta ULC. All rights reserved